- Home
- CLDI vs IMNN Comparison
CLDI vs IMNN Comparison
Compare CLDI & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- IMNN
- Stock Information
- Founded
- CLDI 2014
- IMNN 1982
- Country
- CLDI United States
- IMNN United States
- Employees
- CLDI N/A
- IMNN N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- CLDI Health Care
- IMNN Health Care
- Exchange
- CLDI Nasdaq
- IMNN Nasdaq
- Market Cap
- CLDI 14.0M
- IMNN 13.6M
- IPO Year
- CLDI N/A
- IMNN 1985
- Fundamental
- Price
- CLDI $0.48
- IMNN $0.88
- Analyst Decision
- CLDI Strong Buy
- IMNN Strong Buy
- Analyst Count
- CLDI 2
- IMNN 2
- Target Price
- CLDI $15.00
- IMNN $21.50
- AVG Volume (30 Days)
- CLDI 386.9K
- IMNN 115.3K
- Earning Date
- CLDI 05-13-2025
- IMNN 05-12-2025
- Dividend Yield
- CLDI N/A
- IMNN N/A
- EPS Growth
- CLDI N/A
- IMNN N/A
- EPS
- CLDI N/A
- IMNN N/A
- Revenue
- CLDI N/A
- IMNN N/A
- Revenue This Year
- CLDI N/A
- IMNN N/A
- Revenue Next Year
- CLDI N/A
- IMNN N/A
- P/E Ratio
- CLDI N/A
- IMNN N/A
- Revenue Growth
- CLDI N/A
- IMNN N/A
- 52 Week Low
- CLDI $0.35
- IMNN $0.64
- 52 Week High
- CLDI $4.90
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- CLDI 38.44
- IMNN 45.55
- Support Level
- CLDI $0.41
- IMNN $0.82
- Resistance Level
- CLDI $0.45
- IMNN $0.98
- Average True Range (ATR)
- CLDI 0.07
- IMNN 0.06
- MACD
- CLDI 0.02
- IMNN -0.01
- Stochastic Oscillator
- CLDI 56.57
- IMNN 41.64
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.